GILEAD SCIENCES, INC. (GILD) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00M; Additional Paid in CapitalUSD $9.53B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $95.00M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00M; Additional Paid in CapitalUSD $9.30B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $78.00M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00M; Additional Paid in CapitalUSD $8.93B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $39.00M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00M; Additional Paid in CapitalUSD $8.68B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $36.00M.
GILEAD SCIENCES, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Noncontrolling Interest in Variable Interest Entity USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.00M | $9.53B | $95.00M | $2.20B | $11.83B | $11.74B | 3 month · $232.00M 6 month · $450.00M | 3 month · 131.83 6 month · 134.34 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $1.00M | $9.30B | $78.00M | $14.13B | $23.52B | $23.43B | 3 month · $218.00M | 3 month · 136.54 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $1.00M | $8.93B | $39.00M | $13.73B | $22.70B | $22.62B | 12 month · $899.00M | 12 month · 107.50 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $1.00M | $8.68B | $36.00M | $12.82B | $21.54B | $21.46B | 3 month · $231.00M 9 month · $668.00M | 3 month · 113.25 9 month · 106.13 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $1.00M | $8.37B | $-18.00M | $11.32B | $19.67B | $19.59B | 3 month · $226.00M 6 month · $436.00M | 3 month · 105.88 6 month · 103.87 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $1.00M | $8.14B | $92.00M | $10.93B | $19.16B | $19.08B | 3 month · $211.00M | 3 month · 102.46 | 3 month · $18.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $1.00M | $7.70B | $132.00M | $11.50B | $19.33B | $19.25B | 12 month · $834.00M | 12 month · 79.54 | 12 month · $19.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $1.00M | $7.33B | $73.00M | $11.07B | $18.48B | $18.39B | 3 month · $216.00M 9 month · $613.00M | 3 month · 76.30 9 month · 75.23 | 9 month · $12.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $1.00M | $7.02B | $93.00M | $11.16B | $18.28B | $18.20B | 3 month · $209.00M 6 month · $397.00M | 3 month · 66.67 6 month · 74.59 | 6 month · $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $1.00M | $6.81B | $69.00M | $10.66B | $17.54B | $17.45B | 3 month · $188.00M | 3 month · 76.88 | 3 month · $-5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $1.00M | $6.50B | $28.00M | $16.30B | $22.83B | $22.75B | 12 month · $767.00M | 12 month · 79.52 | 12 month · $49.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $1.00M | $6.28B | $31.00M | $16.00B | $22.31B | $22.24B | 3 month · $202.00M 9 month · $566.00M | 3 month · 77.08 9 month · 79.92 | 9 month · $42.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $1.00M | $6.01B | $10.00M | $15.14B | $21.16B | $21.09B | 3 month · $198.00M 6 month · $363.00M | 3 month · 79.68 6 month · 81.56 | 6 month · $28.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $1.00M | $5.79B | $-20.00M | $15.22B | $21.00B | $20.94B | 3 month · $165.00M | 3 month · 82.29 | 3 month · $20.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $1.00M | $5.55B | $2.00M | $15.69B | $21.24B | $21.21B | 12 month · $640.00M | 12 month · 73.77 | 12 month · $170.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $1.00M | $5.23B | $98.00M | $15.76B | $21.08B | $21.06B | 3 month · $170.00M 9 month · $465.00M | 3 month · 63.10 9 month · 63.34 | 9 month · $99.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $1.00M | $5.03B | $87.00M | $15.12B | $20.24B | $20.21B | 3 month · $164.00M 6 month · $295.00M | 3 month · 61.83 6 month · 63.44 | 6 month · $58.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $1.00M | $4.87B | $73.00M | $14.99B | $19.93B | $19.91B | 3 month · $131.00M | 3 month · 63.78 | 3 month · $20.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $1.00M | $4.66B | $83.00M | $16.32B | $21.07B | $21.06B | 12 month · $640.00M | 12 month · 66.58 | 12 month · $-58.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $1.00M | $4.49B | $74.00M | $16.90B | $21.47B | $21.47B | 3 month · $171.00M 9 month · $479.00M | (m) | 9 month · $-60.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $1.00M | $4.27B | $39.00M | $15.39B | $19.70B | $19.71B | 3 month · $168.00M 6 month · $308.00M | (m) | 6 month · $-42.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $1.00M | $4.09B | $38.00M | $14.82B | $18.95B | $18.96B | 3 month · $140.00M | (m) | 3 month · $-22.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $1.00M | $3.88B | $-60.00M | $14.38B | $18.20B | $18.22B | 12 month · $642.00M | 12 month · 70.64 | 12 month · $83.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $1.00M | $3.71B | $23.00M | $13.71B | $17.45B | $17.47B | 3 month · $173.00M 9 month · $482.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $1.00M | $3.51B | $70.00M | $14.45B | $18.03B | $18.14B | 3 month · $168.00M 6 month · $309.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $1.00M | $3.31B | $46.00M | $18.71B | $22.07B | $22.18B | 3 month · $141.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $1.00M | $3.05B | $85.00M | $19.39B | $22.52B | $22.65B | 12 month · $638.00M | 12 month · 66.36 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $1.00M | $2.87B | $117.00M | $17.62B | $20.60B | $20.74B | 3 month · $160.00M 9 month · $479.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $1.00M | $2.68B | $102.00M | $19.83B | $22.62B | $22.75B | 3 month · $175.00M 6 month · $319.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $1.00M | $2.49B | $130.00M | $19.33B | $21.95B | $22.09B | 3 month · $144.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $1.00M | $2.28B | $80.00M | $19.02B | $21.39B | $21.53B | 12 month · $842.00M | 12 month · 72.95 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | $1.00M | $2.12B | $36.00M | $20.71B | $22.86B | $23.01B | 3 month · $190.00M 9 month · $667.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-07-19 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $82.00M | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $1.00M | $1.84B | $2.00M | $19.82B | $21.67B | $21.73B | 3 month · $253.00M 6 month · $477.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $0.00 | $1.00M | $1.56B | $-170.00M | $19.20B | $20.59B | $20.65B | 3 month · $224.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $19.20B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $0.00 | $1.00M | $1.26B | $165.00M | $19.01B | $20.44B | $20.50B | 12 month · $618.00M | 12 month · 71.79 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $1.00M | $906.00M | $249.00M | $23.69B | $24.84B | $25.25B | 9 month · $305.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $0.00 | $1.00M | $733.00M | $120.00M | $21.82B | $22.68B | $23.09B | 6 month · $191.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $1.00M | $616.00M | $260.00M | $19.56B | $20.44B | $20.92B | 3 month · $89.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $1.00M | $454.00M | $278.00M | $18.15B | $18.89B | $19.36B | 12 month · $381.00M | 12 month · 89.15 | (m) | (m) | (m) | 12 month · $2.00M | 12 month · $733.00M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $186.00M |
| 2016-09-30 | $0.00 | $1.00M | $321.00M | $-108.00M | $16.65B | $16.87B | $17.36B | 9 month · $278.00M | (m) | 9 month · $67.00M | (m) | (m) | 9 month · $2.00M | 9 month · $733.00M | (m) | 9 month · $469.00M | (m) | (m) | (m) | (m) | 9 month · $157.00M |
| 2016-06-30 | $0.00 | $1.00M | $632.00M | $-46.00M | $14.95B | $15.54B | $16.11B | 6 month · $183.00M | (m) | 6 month · $71.00M | (m) | (m) | 6 month · $2.00M | 6 month · $733.00M | (m) | (m) | 6 month · $733.00M | (m) | (m) | (m) | 6 month · $125.00M |
| 2016-03-31 | $0.00 | $1.00M | $516.00M | $-164.00M | $13.04B | $13.40B | $14.02B | 3 month · $88.00M | (m) | 3 month · $80.00M | (m) | (m) | 3 month · $2.00M | 3 month · $-733.00M | (m) | (m) | 3 month · $733.00M | (m) | (m) | (m) | 3 month · $87.00M |
| 2015-12-31 | $0.00 | $1.00M | $444.00M | $88.00M | $18.00B | $18.53B | $19.11B | 12 month · $384.00M | 12 month · 104.91 | 12 month · $582.00M | (m) | (m) | 12 month · $13.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $586.00M |
| 2015-09-30 | $0.00 | $1.00M | $285.00M | $167.00M | $16.96B | $17.41B | $17.94B | 9 month · $285.00M | (m) | 9 month · $455.00M | (m) | (m) | 9 month · $11.00M | (m) | 9 month · $-599.00M | (m) | (m) | (m) | (m) | (m) | 9 month · $499.00M |
| 2015-06-30 | $0.00 | $2.00M | $0.00 | $247.00M | $16.04B | $16.29B | $16.63B | 6 month · $188.00M | (m) | 6 month · $323.00M | (m) | (m) | 6 month · $8.00M | (m) | 6 month · $-508.00M | (m) | (m) | (m) | 6 month · $151.00M | (m) | 6 month · $326.00M |
| 2015-03-31 | $0.00 | $1.00M | $2.72B | $539.00M | $13.92B | $17.18B | $17.59B | (m) | (m) | 3 month · $-141.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | $2.00M | $2.39B | $301.00M | $12.73B | $15.43B | $15.82B | 12 month · $362.00M | 12 month · 90.29 | 12 month · $-4.00M | (m) | (m) | 12 month · $49.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $484.00M |
| 2014-09-30 | $0.00 | $1.51M | $2.14B | $173.96M | $11.25B | $13.57B | $13.86B | (m) | (m) | 9 month · $-43.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $0.00 | $1.53M | $5.93B | $-41.46M | $10.20B | $16.09B | $16.43B | (m) | (m) | 6 month · $-41.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $0.00 | $1.54M | $5.75B | $-95.77M | $7.73B | $13.39B | $13.70B | (m) | (m) | 3 month · $-21.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | $2.00M | $5.39B | $-124.00M | $6.11B | $11.37B | $11.74B | 12 month · $254.00M | 12 month · 60.78 | 12 month · $-21.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $285.00M |
| 2013-09-30 | $0.00 | $763.00K | $5.19B | $-42.07M | $5.74B | $10.88B | $11.19B | (m) | (m) | 9 month · $2.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $0.00 | $765.00K | $6.00B | $30.37M | $5.07B | $11.09B | $11.34B | (m) | (m) | 6 month · $-5.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $0.00 | $760.00K | $5.83B | $20.81M | $4.30B | $10.15B | $10.39B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | $1.52M | $5.64B | $-46.00M | $3.70B | $9.30B | $9.54B | 12 month · $208.00M | 12 month · 28.93 | (m) | $-1.42M | $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-51.70M | 12 month · $113.00M |
| 2012-09-30 | $0.00 | $758.00K | $5.44B | $28.25M | $3.14B | $8.60B | $8.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $0.00 | $756.00K | $5.21B | $124.38M | $2.66B | $8.00B | $8.08B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $0.00 | $758.00K | $5.10B | $33.59M | $2.18B | $7.31B | $7.36B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | $753.00K | $4.90B | $58.20M | $1.78B | $6.74B | $6.87B | 12 month · $192.03M | 12 month · 19.90 | (m) | $-12.50M | $-26.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $97.44M | 12 month · $37.23M |
| 2011-09-30 | (m) | $757.00K | $4.81B | $-15.54M | $1.32B | $6.12B | $6.23B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $777.00K | $4.78B | $-133.28M | $1.40B | $6.05B | $6.21B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $791.00K | $4.73B | $-101.18M | $1.32B | $5.95B | $6.18B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $0.00 | $802.00K | $4.65B | $30.91M | $1.18B | $5.86B | $6.12B | (m) | (m) | (m) | $-7.23M | $16.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $21.61M | 12 month · $82.09M |
| 2010-09-30 | $0.00 | $815.00K | $4.58B | $7.49M | $1.12B | $5.71B | $5.88B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.90M | (m) |
| 2010-06-30 | (m) | $860.00K | $4.54B | $189.62M | $1.83B | $6.56B | $6.70B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $186.10M | (m) |
| 2010-03-31 | (m) | $902.00K | $4.57B | $83.47M | $2.69B | $7.34B | $7.50B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $0.00 | $900.00K | $4.38B | $-5.76M | $2.00B | $6.37B | $6.51B | (m) | (m) | (m) | $1.18M | $9.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-16.45M | 12 month · $88.37M |
| 2009-09-30 | $0.00 | $902.00K | $4.26B | $-39.20M | $1.42B | $5.65B | $5.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | $0.00 | $905.00K | $4.15B | $23.29M | $1.02B | $5.19B | $5.31B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $0.00 | $910.00K | $3.93B | $41.24M | $300.31M | $4.27B | $4.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $209.52M |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $3.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $110.68M |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $2.05B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |